HealthEquity (NASDAQ:HQY) Updates FY25 Earnings Guidance

HealthEquity (NASDAQ:HQY) issued an update on its FY25 earnings guidance on Monday morning. The company provided EPS guidance of 3.08-3.16 for the period, compared to the consensus EPS estimate of $3.12. The company issued revenue guidance of $1.185-1.195 billion, compared to the consensus revenue estimate of $1.18 billion.

Analyst Ratings Changes

Several analysts recently issued reports on HQY shares. Deutsche Bank Aktiengesellschaft lifted their target price on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. JMP Securities restated a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Mizuho initiated coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. Royal Bank of Canada restated an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Finally, Barrington Research boosted their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $109.64.

HealthEquity Trading Up 0.8 %

Shares of NASDAQ:HQY traded up $0.79 during trading hours on Monday, hitting $101.00. 1,207,795 shares of the company’s stock traded hands, compared to its average volume of 626,324. The business has a fifty day moving average price of $92.42 and a 200-day moving average price of $83.64. HealthEquity has a 1 year low of $62.10 and a 1 year high of $105.82. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The firm has a market capitalization of $8.82 billion, a P/E ratio of 84.53, a price-to-earnings-growth ratio of 1.57 and a beta of 0.55.

Insider Activity

In other news, Director Frank Corvino sold 1,247 shares of the company’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the sale, the director now owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. This represents a 20.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 10,536 shares of company stock valued at $884,517. 2.20% of the stock is currently owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.